Table 1.
Donors <50 years old (N=22) | Donors >50 years old (N=31) | Statistical significance | |
---|---|---|---|
Age (Years) | 37 ± 10 | 74 ± 9 | P<0.0001 |
A2E in macula (ng) | 1.3 ± 0.5 | 2.7 ± 1.1 | P<0.001 |
A2E in periphery (ng) | 5.1 ± 2.6 | 9.1 ± 4.6 | P<0.0001 |
Iso-A2E in macula (ng) | 0.1 ± 0.1 | 0.8 ± 0.4 | P<0.01 |
Iso-A2E in periphery (ng) | 0.5 ± 0.2 | 1.4 ± 0.9 | P<0.0001 |
Total carotenoids in macula (ng) | 43.6 ± 14.6 | 38 ± 15.1 | P<0.001 |
Total carotenoids in periphery (ng) | 2.6 ± 2.2 | 2.8 ± 2.8 | Not significant |
These data exclude outliers with unusually high levels of ocular carotenoids who had been consuming high-dose lutein supplements regularly prior to death because of potential confounding effects on data interpretation since exact dosage and duration of supplementation were unknown [16].